| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 119, 349-356, Copyright © 1986 by Endocrine Society
ARTICLES |
GA Nickols, MA Metz and WH Cline Jr
We examined the mechanisms involved in the relaxation of rat vascular smooth muscle by PTH. PTH increased intracellular cAMP 10-fold in cultured vascular smooth muscle cells from rat aorta. Forskolin, methylisobutylxanthine, and papaverine all potentiated PTH action. The cAMP responses to PTH were not altered by concurrent addition of propranolol, phentolamine, atropine, or [Sar1,Ile8]angiotensin II. Only the synthetic PTH antagonist analog [Nle8,Nle18,Tyr34] bovine PTH-(3- 34) inhibited the cAMP and vascular relaxation responses to PTH. Isoproterenol produced increases in intracellular cAMP and adenylate cyclase activity which were additive to those produced by PTH. In contracted rat aortic strips, PTH caused a dose-dependent relaxation which was not altered by removal of the vessel intima or treatment with nordihydroguaiaretic acid. Also, membrane preparations from intact aortas or aortas with the endothelium or adventitia removed displayed identical PTH-stimulated adenylate cyclase activities. These findings indicate that the relaxant action of PTH in rat aorta does not require an intact endothelium and results from a direct effect on the vessel medial layer. Relaxation appears to be mediated by a receptor unique for PTH which is linked to the adenylate cyclase of vascular smooth muscle cells.
This article has been cited by other articles:
![]() |
P. Andersson, E. Rydberg, and R. Willenheimer Primary hyperparathyroidism and heart disease -- a review Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Isales, B. Sumpio, R. J. Bollag, Q. Zhong, K.-H. Ding, W. Du, J. Rodriguez-Commes, R. Lopez, O. R. Rosales, J. Gasalla-Herraiz, et al. Functional parathyroid hormone receptors are present in an umbilical vein endothelial cell line Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E654 - E662. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sutliff, C. S. Weber, J. Qian, M. L. Miller, T. L. Clemens, and R. J. Paul Vasorelaxant Properties of Parathyroid Hormone-Related Protein in the Mouse: Evidence for Endothelium Involvement Independent of Nitric Oxide Formation Endocrinology, May 1, 1999; 140(5): 2077 - 2083. [Abstract] [Full Text] |
||||
![]() |
T. Massfelder and J.-J. Helwig Editorial: Parathyroid Hormone-Related Protein in Cardiovascular Development and Blood Pressure Regulation Endocrinology, April 1, 1999; 140(4): 1507 - 1510. [Full Text] |
||||
![]() |
N. Amizuka, H. S. Lee, M. Y. Kwan, A. Arazani, H. Warshawsky, G. N. Hendy, H. Ozawa, J. H. White, and D. Goltzman Cell-Specific Expression of the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene in Kidney from Kidney-Specific and Ubiquitous Promoters Endocrinology, January 1, 1997; 138(1): 469 - 481. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |